Cantor Fitzgerald upgraded shares of Zevra Therapeutics (NASDAQ:ZVRA – Free Report) to a strong-buy rating in a research note issued to investors on Wednesday,Zacks.com reports. Other equities ...

Check the time stamp on this data. Updated AI-Generated Signals for Zevra Therapeutics Inc. (ZVRA) available here: ZVRA. Type ...

Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...

SOUTH SAN FRANCISCO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the ...

CELEBRATION, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that ...

XOMA Royalty Corp (NASDAQ:XOMA), a $313 million market cap company, experienced a significant stock sale as reported in a recent SEC filing. Several major investors, including BVF Partners L.P., ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

Analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Zevra Therapeutics in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst L. Chen ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Zevra Therapeutics, Inc. (NASDAQ:ZVRA), that sends out a ...